ArticleNature communications2024

Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19.

Yongzhi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.